Alkermes Fined Over Huge Price Hikes
Company found to have overcharged for older-generation cancer drugs in Italy
Major South African generic drug manufacturer Aspen Pharmacare has been fined ß5-million (R76.4-million) by Italian competition authorities for pushing the prices of older-generation blood cancer drugs sky-high, potentially disrupting their supply.
Aspen, which has extensive operations in Port Elizabeth, started manufacturing generic medication in South Africa and now manufactures or supplies medicines in 150 countries.
Major South African generic drug manufacturer Aspen Pharmacare has been fined ß5-million (R76.4-million) by Italian competition authorities for pushing the prices of older-generation blood cancer drugs sky-high, potentially disrupting their supply.
Aspen, which has extensive operations in Port Elizabeth, started manufacturing generic medication in South Africa and now manufactures or supplies medicines in 150 countries.